Animal and drug modelling for Alzheimer synaptic pathology
Data up to Jan 2025
Total Citations Per Year
Abstract
References (186)
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Neuropathological stageing of Alzheimer-related changes
1991 • 14,533 citations
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
1991 • 4,120 citations
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5
1986 • 3,586 citations
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
1982 • 3,563 citations
Psychopharmacology: The third generation of progress
1988 • 3,403 citations
Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein
1991 • 2,613 citations
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
1990 • 2,131 citations
Excitatory amino acid neurotoxicity and neurodegenerative disease
1990 • 1,781 citations
Human Memory and the Cholinergic System
1974 • 1,378 citations
NMDA receptors - their role in long-term potentiation
1987 • 1,177 citations
Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
1986 • 1,148 citations
Excitatory amino acid receptors and synaptic plasticity
1990 • 872 citations
The Cholinergic Synapse and the Site of Memory
1972 • 741 citations
Intramuscular desferrioxamine in patients with Alzheimer's disease
1991 • 723 citations
The Natural History of Mental Disorder in Old Age
1955 • 713 citations
The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings
1991 • 674 citations
β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
1990 • 620 citations
5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex
1991 • 599 citations
Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence
1991 • 598 citations
Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
1987 • 569 citations
Dementia of frontal lobe type.
1988 • 550 citations
Prevalence and Malignancy of Alzheimer Disease
1976 • 515 citations
Excitatory amino acids and Alzheimer's disease
1989 • 485 citations
G Proteins in Signal Transduction
1990 • 479 citations
The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions
1991 • 467 citations
Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin
1987 • 463 citations
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
1979 • 459 citations
Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease
1983 • 440 citations
Presynaptic Cholinergic Dysfunction in Patients with Dementia
1983 • 422 citations
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
1991 • 421 citations
Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings
1991 • 383 citations
Psychiatric Phenomena in Alzheimer's Disease. IV: Disorders of Behaviour
1990 • 382 citations
Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis
1987 • 376 citations
The Clinical Efficacy of Citalopram in Treatment of Emotional Disturbances in Dementia Disorders a Nordic Multicentre Study
1990 • 375 citations
Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia
1981 • 362 citations
Neurochemical Studies of Early-Onset Alzheimer's Disease
1985 • 356 citations
Convergence and divergence of neurotransmitter action in human cerebral cortex.
1989 • 349 citations
Synaptic targets of HRP-filled layer III pyramidal cells in the cat striate cortex
1986 • 324 citations
Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts
1985 • 313 citations
Intravenous nicotine in Alzheimer's disease: a pilot study
1988 • 312 citations
Correlation between Scores for Dementia and Counts of ‘Senile Plaques’ in Cerebral Grey Matter of Elderly Subjects
1966 • 293 citations
Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis
1988 • 289 citations
Serotonin, memory, and the aging brain
1991 • 287 citations
Alzheimer's disease: a correlative study.
1986 • 269 citations
D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats
1989 • 253 citations
Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study
1978 • 252 citations
A STUDY OF THALAMO-STRIATE RELATIONS IN THE MONKEY
1956 • 240 citations
Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia.
1987 • 238 citations
Psychiatric Phenomena in Alzheimer's Disease. III: Disorders of Mood
1990 • 234 citations
The effects of physostigmine and scopolamine on recognition memory in monkeys
1986 • 224 citations
Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone
1987 • 221 citations
The Molecular basis of neuropathology
1981 • 217 citations
The role of cholinergic projections from the nucleus basalis in memory
1991 • 213 citations
Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease
1987 • 213 citations
The Cholinergic Hypothesis of Memory: A Review of Animal Experiments
1988 • 210 citations
Biological Aspects of Alzheimer's Disease
1984 • 203 citations
Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease
1988 • 200 citations
Two distinct effects of 5-hydroxytryptamine on single cortical neurons
1987 • 197 citations
Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study
1990 • 195 citations
Possible neurotransmitter basis of behavioral changes in alzheimer's disease
1988 • 190 citations
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease
1987 • 185 citations
Learning and memory
1977 • 183 citations
Suicide Transport: Destruction of Neurons by Retrograde Transport of Ricin, Abrin, and Modeccin
1982 • 178 citations
Cholinergic Basis for Alzheimer Therapy
1991 • 177 citations
Mitochondrial function in brain tissue in primary degenerative dementia
1987 • 177 citations
Nerve growth factor potentiates the neurotoxicity of beta amyloid.
1990 • 171 citations
Tacrine: A pharmacological review
1991 • 168 citations
Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2 -activated interneuron
1990 • 167 citations
Cajal on the Cerebral Cortex: An Annotated Translation of the Complete Writings
1989 • 166 citations
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
1986 • 155 citations
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease
1985 • 150 citations
Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.
1989 • 148 citations
A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease
1988 • 146 citations
Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus
1987 • 144 citations
Selective localization of striatal D1 receptors to striatonigral neurons
1990 • 143 citations
Postsynaptic 5-HT1 receptors and offensive aggression in rats: A combined behavioural and autoradiographic study with eltoprazine
1991 • 138 citations
Topographical distribution of neurochemical changes in Alzheimer's disease
1988 • 137 citations
Cognitive deficits in olivopontocerebellar atrophy: Implications for the cholinergic hypothesis of Alzheimer's dementia
1988 • 137 citations
CHEMICAL PATHOLOGY OF THE ORGANIC DEMENTIAS
1977 • 134 citations
AN ELECTRON MICROSCOPIC STUDY OF THE TYPES AND PROPORTIONS OF NEURONS IN THE CORTEX OF THE MOTOR AND VISUAL AREAS OF THE CAT AND RAT
1980 • 134 citations
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease
1987 • 131 citations
An Immunotoxin Composed of Monoclonal Anti-Thy 1.1 Antibody and a Ribosome-Inactivating Protein From <italic>Saponaria officinalis:</italic> Potent Antitumor Effects In Vitro and In Vivo
1985 • 130 citations
GAMMA-AMINOBUTYRIC ACID CONCENTRATION IN BRAIN TISSUE AT TWO STAGES OF ALZHEIMER'S DISEASE
1988 • 130 citations
5.HT1 receptors in the vertebrate brain
1989 • 126 citations
Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease
1990 • 121 citations
Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease
1986 • 118 citations
Is ethylcholine mustard aziridinium ion a specific cholinergic neurotoxin?
1987 • 116 citations
Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus
1991 • 113 citations
Etiology of dementia of Alzheimer's type
1989 • 111 citations
Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
1986 • 110 citations
Binding of the Novel Serotonin Agonist 8‐Hydroxy‐2‐(Di‐n‐Propylamino) Tetralin in Normal and Alzheimer Brain
1986 • 105 citations
RETRACTED ARTICLE: Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein
1991 • 104 citations
Alzheimer's disease
1987 • 103 citations
Learning and memory
1991 • 101 citations
Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.
1990 • 100 citations
Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
1991 • 100 citations
Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.
1990 • 100 citations
Multiple-Dose Arecoline Infusions in Alzheimer's Disease
1988 • 99 citations
Selective vulnerability of neurones in organic dementia
1977 • 99 citations
MENTAL ILLNESS AND THE AGEING BRAIN
1963 • 98 citations
A critical evaluation of monkey models of amnesia and dementia
1991 • 98 citations
Induction of depression with oxotremorine in patients with Alzheimer's disease
1987 • 94 citations
Cortical GABA B and GABA A receptors in Alzheimer's disease
1987 • 94 citations
Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease
1990 • 94 citations
Hyperresponsivity to the Serotonin Agonist m-Chlorophenylpiperazine in Alzheimer's Disease
1989 • 91 citations
Biology of Serotonergic Transmission
1983 • 91 citations
A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease.
1990 • 90 citations
Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents
1989 • 90 citations
Lack of Efficacy of Hydergine in Patients with Alzheimer's Disease
1990 • 90 citations
Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in the rat
1985 • 90 citations
Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG
1987 • 88 citations
A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease
1991 • 88 citations
RS 86 in the treatment of alzheimer's disease: Cognitive and biological effects
1987 • 87 citations
The nature of wandering in dementia: A community‐based study
1990 • 87 citations
The connexions of the midline and intralaminar nuclei of the thalamus of the rat.
1954 • 83 citations
No response to high‐dose muscarinic agonist therapy in Alzheimer's disease
1988 • 80 citations
Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
1990 • 78 citations
Properties of volkensin, a toxic lectin from Adenia volkensii.
1985 • 78 citations
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease
1983 • 77 citations
Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors
1988 • 77 citations
M-current in human neocortical neurones
1986 • 75 citations
Glycine prodrug facilitates memory retrieval in humans
1991 • 75 citations
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
1984 • 72 citations
Robustness of G Proteins in Alzheimer's Disease: An Immunoblot Study
1991 • 71 citations
Abnormal Temporal Lobe Response in Alzheimer's Disease during Cognitive Processing as Measured by 11C-2-Deoxy-D-Glucose and PET
1987 • 63 citations
Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms
1992 • 63 citations
d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain
1991 • 63 citations
Loss of glycine-dependent radioligand binding to the receptor complex in patients with Alzheimer's disease
1989 • 63 citations
In situ hybridization histochemistry and the study of gene expression in the human brain
1990 • 62 citations
Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal corte by mesencephalic raphe nuclei
1990 • 61 citations
Alzheimer's Disease
1969 • 61 citations
Modeccin and volkensin but not abrin are effective suicide transport agents in rat CNS
1988 • 61 citations
Somatostatin content and release measured in cerebral biopsies from demented patients
1987 • 60 citations
Increased density of excitatory amino acid transport sites in the hippocampal formation following an entorhinal lesion
1991 • 58 citations
Treatment of Alzheimer's Disease
1990 • 57 citations
Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat.
1990 • 56 citations
A double‐blind comparison of alaproclate and placebo in the treatment of patients with senile dementia
1985 • 54 citations
Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats
1980 • 53 citations
Na+‐Dependent “Binding” of D‐Aspartate in Brain Membranes Is Largely Due to Uptake into Membrane‐Bounded Saccules
1986 • 52 citations
Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
1991 • 52 citations
Disruption of memory produced by stimulation of the dorsal raphe nucleus: mediation by serotonin
1978 • 51 citations
The evoked release of endogenous amino acids from tissue prisms of human neocortex
1983 • 51 citations
Alzheimer's disease: is there a problem beyond recognition?
1990 • 50 citations
Glutamic Acid as a Putative Transmitter of the Interhemispheric Corticocortical Connections in the Rat
1986 • 48 citations
Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist
1991 • 46 citations
Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients
1984 • 44 citations
GABA-Agonist Therapy for Alzheimerʼs Disease
1986 • 44 citations
Galanin‐Like Immunoreactivity Is Unchanged in Alzheimer's Disease and Parkinson's Disease Dementia Cerebral Cortex
1988 • 44 citations
Primary degeneration of motor neurons by toxic lectins conveyed from the peripheral nerve
1985 • 43 citations
The association of [3H]d-aspartate binding and high-affinity glutamate uptake in the human brain
1986 • 43 citations
Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: Dissociable serotoninergic involvement in avoidance learning, pain and motor function
1985 • 42 citations
Ricin transport distinguishes between central and peripheral neurons
1983 • 41 citations
Mental Illness and The Ageing Brain
1963 • 38 citations
Neuronotoxic effects of monoclonal anti-Thy 1 antibody (OX7) coupled to the ribosome inactivating protein, saporin, as studied by suicide transport experiments in the rat
1989 • 38 citations
Age dependent effects of 5-hydroxytryptamine upon memory consolidation and cerebral protein synthesis
1973 • 38 citations
Sodium-dependentd-aspartate ‘binding’ is not a measure of presynaptic neuronal uptake sites in an autoradiographic assay
1990 • 37 citations
Cholinesterase and its molecular forms in pathological states
1988 • 36 citations
A new method for quenching correction leads to revisions of data in receptor autoradiography
1990 • 35 citations
NEURONOTOXICITY OF AXONALLY TRANSPORTED TOXIC LECTINS, ABRIN, MODECCIN AND VOLKENSIN IN RAT PERIPHERAL NERVOUS SYSTEM
1987 • 35 citations
Characterisation of the Glycine Modulatory Site of the N‐Methyl‐<scp>d</scp>‐Aspartate Receptor‐Ionophore Complex in Human Brain
1991 • 34 citations
A review of neuropathological and neurochemical correlates of Alzheimer's disease.
1985 • 29 citations
Destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin from Adenia volkensii
1991 • 29 citations
Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.
1993 • 27 citations
Effect of Central Cholinergic Stimulation on Regional Cerebral Blood Flow in Alzheimer's Disease
1991 • 26 citations
Somatostatin replacement therapy for alzheimer dementia
1991 • 25 citations
Electrophysiological effects of tianeptine on rat locus coeruleus, raphe dorsalis, and hippocampus activity.
1988 • 25 citations
Studies in presenile dementia.
1961 • 23 citations
Spermidine enhancement of [3H]MK-801 binding to the NMDA receptor complex in human cortical membranes
1990 • 22 citations
Analgesia induced by brief or more prolonged stress differs in its dependency on naloxone, 5-hydroxytryptamine and previous testing of analgesia
1984 • 22 citations
Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype
1991 • 19 citations
The design of full agonists for the cortical muscarinic receptor.
1989 • 16 citations
Neurobiology of the NMDA receptor: From chemistry to the clinic
1992 • 16 citations
Anatomical and neurochemical evidence for suicide transport of a toxic lectin, volkensin, injected in the rat dorsal hippocampus
1990 • 16 citations
Therapy for Alzheimerʼs Disease: Choosing a Target
1991 • 13 citations
Topography of the glycine site of the NMDA receptor
1990 • 12 citations
New Intrathecal Drugs in Alzheimer's Disease and Psychometric Testing
1988 • 12 citations
Alzheimer's Disease: towards an understanding of the aetiology and pathogenesis
1990 • 10 citations
High affinity serotonin binding sites in human brain: a comparison of cerebral cortex and basal ganglia
1989 • 10 citations
Neurochemical studies of early-onset Alzheimerʼs disease
1987 • 10 citations
Toward a Third Generation of Cholinesterase Inhibitors
1991 • 7 citations
A Topological Model of the NMDA-Glycine Receptor Model
1990 • 7 citations
Effects of tetrahydroaminoacridine (THA) on functional recovery after sequential lesion of the entorhinal cortex
1991 • 6 citations
Molecular Neuropathology
1996 • 5 citations
10. THA, A putative drug in the treatment of Alzheimer's disease?
2009 • 3 citations
Neurotransmitter uptake and binding in ischaemia and organic dementia.
1980 • 2 citations